FDG PET can determine breast cancer patients not responding to chemo

01/11/2010 | HealthImaging.com

In an Italian study, 18F-FDG PET scans used to monitor patients with estrogen receptor-positive breast cancer tumors showed that 30% of the participants were unresponsive to preoperative chemotherapy. The standardized uptake value threshold needed to determine pathologic response was 50% after the second cycle of treatment, the researchers said.

View Full Article in:

HealthImaging.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Behavioral Health Operations
Meridian Health Plan
Detroit, MI
Medical Director
PacificSource
Bend, OR
Clinical Appeals RN
MJHS
Brooklyn, NY
Director of Clinical Operations
Meridian Health Plan
Detroit, MI
Sr. Director, Regulatory Compliance Intelligence and Outreach
Johnson & Johnson
New Brunswick, NJ